Please check your internet connection and try again.
# Sompraz HP (Sompraz HP is not a recognized drug name. Assuming the request is for **esomeprazole**.)
## Overview
Esomeprazole is a proton pump inhibitor (PPI) that reduces stomach acid production.
## Primary Indications
* Gastroesophageal reflux disease (GERD) - erosive esophagitis healing and maintenance, symptomatic GERD treatment.
* Treatment of *Helicobacter pylori* infection (in combination with antibiotics).
* Prevention of NSAID-induced gastric ulcers.
* Zollinger-Ellison syndrome.
## Adult Dosing
* **GERD (Erosive Esophagitis Healing):** 20 mg or 40 mg orally once daily for 4 to 8 weeks.
* **GERD (Maintenance of Healing):** 20 mg orally once daily.
* **Symptomatic GERD:** 20 mg orally once daily for 4 weeks.
* ***H. pylori* Eradication (Triple Therapy):** 20 mg orally twice daily for 10 days (in combination with amoxicillin and clarithromycin).
* ***H. pylori* Eradication (Quadruple Therapy):** 20 mg orally once daily for 14 days (in combination with bismuth subsalicylate, tetracycline, and metronidazole).
* **NSAID-Induced Gastric Ulcer Prevention:** 20 mg orally once daily.
* **Zollinger-Ellison Syndrome:** Initiate at 40 mg orally twice daily. Adjust dose as needed. Maximum dose generally 40 mg twice daily, but higher doses may be used if clinically indicated.
## Pediatric Dosing
Dosing in children varies by indication and age/weight. Consult specific pediatric guidelines or product labeling for precise dosing.
* **GERD (Erosive Esophagitis Healing, 1-11 years):** 10 mg or 20 mg orally once daily for up to 8 weeks.
* **GERD (Symptomatic Treatment, 1-11 years):** 10 mg orally once daily for up to 4 weeks.
## Dose Adjustments
No dose adjustment is typically required for hepatic or renal impairment, although caution may be advised in severe hepatic impairment.
## Contraindications
* Known hypersensitivity to esomeprazole, other PPIs, or any component of the formulation.
## Adverse Effects
Common adverse effects include headache, diarrhea, nausea, vomiting, and abdominal pain. Long-term PPI use may be associated with an increased risk of *Clostridium difficile* infection, bone fractures, hypomagnesemia, and vitamin B12 deficiency.
## Key Drug Interactions
* **Drugs affected by gastric pH:** Esomeprazole can decrease absorption of drugs requiring an acidic environment (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors, cyanocobalamin).
* **CYP2C19 substrates:** May inhibit CYP2C19, potentially increasing levels of drugs metabolized by this enzyme (e.g., clopidogrel, citalopram, diazepam).
* **Methotrexate:** Concomitant use may increase methotrexate levels.
## Monitoring
* Monitor for effectiveness and signs of adverse effects.
* Monitor magnesium levels, especially with long-term use or concurrent diuretic use.
* Consider vitamin B12 levels with long-term therapy.
## Clinical Pearls
* Administer capsules or tablets 1 hour before a meal.
* For patients with dysphagia, the capsule contents can be mixed with applesauce or taken as a slurry with water and left to stand for 1 minute before drinking.
* Long-term PPI use should be periodically re-evaluated for continued need.
**Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always consult current prescribing information and your healthcare provider for any medical decisions.